The awards celebrate Megan Ehret’s impactful leadership in mental health pharmacy and advocacy, and Kimberly Claeys’ pioneering role in diagnostic and antimicrobial stewardship.

The Behavioral Health Resources and Technical Assistance Program drives data and substance solutions.

Researchers aim to improve chemotherapy by enhancing drug efficacy and reducing heart toxicity through dual activation of CAR and Nrf2 pathways.

The University of Maryland, Baltimore (UMB) is building on its focus on innovative health care through a new partnership that will allow the university to advance its mission of improving the human condition.

Graduates poised to lead, innovate, and improve care for patients and families facing serious illness.

Celebrating big wins at AACP 2025, from top research awards to national leadership roles.

Paul Shapiro, PhD, and Jeffrey Hasday, MD, are developing a class of drugs that may be able to reset the natural balance of inflammation and prevent a number of serious diseases.

The Mass Spectrometry Center at UMSOP is a collaborative hub where cutting-edge instrumentation and scientific expertise come together to solve complex research challenges and support groundbreaking discoveries across the globe.

Researchers are developing a novel therapy using safe, drug-free nanoparticles to aid the body in fighting sepsis more effectively.

Allan Doctor, MD, of the School of Medicine and Joga Gobburu, PhD, MBA, of the School of Pharmacy are optimistic they are on the cusp of developing the world’s first viable artificial blood.

International relationship focuses on global health education, research, and interprofessional collaboration.

Expansion will enhance public health and communication across Maryland and District of Columbia.